Radius Health (RDUS) Tops Q4 EPS by 19c, Revenues Beat
Radius Health (NASDAQ: RDUS) reported Q4 EPS of ($0.23), $0.19 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $62.78 million versus the consensus estimate of $59.44 million.
For earnings history and earnings-related data on Radius Health (RDUS) click here.
